Literature DB >> 8709246

A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.

J A Beatty1, B J Willett, E A Gault, O Jarrett.   

Abstract

The evolution of the virus-specific cytotoxic T-lymphocyte response in two cats experimentally infected with feline immunodeficiency virus (FIV) was monitored. Effector cells were derived from peripheral blood lymphocytes during the acute and chronic phases of infection (0 to 21 and 62 to 127 weeks, respectively) and from the spleen and lymph nodes at 127 weeks after infection. Lymphocytes were restimulated in vitro with paraformaldehyde-fixed, autologous lymphoblasts which had been infected with recombinant vaccinia viruses expressing FIV GAG or ENV proteins. Unstimulated lymphocytes were also used as effectors in some assays. 51Cr-labelled autologous skin fibroblasts infected with recombinant vaccinia viruses were used as targets. FIV GAG-specific cytotoxic precursors were detected in restimulated circulating lymphocytes during acute infection in both cats. The onset of this activity was as early as 2 weeks postinfection (p.i.) in one cat. From 62 weeks p.i. neither FIV GAG- nor ENV-specific precursors could be detected in the peripheral blood. However, at 127 weeks p.i., GAG- and ENV-specific cytotoxic precursors were detected in lymphocytes isolated from lymph nodes. The FIV-specific cytotoxic cells were predominantly major histocompatibility complex class I restricted. No cytotoxic activity was detected from unstimulated lymphocytes. These studies demonstrate the use of an assay system for dissecting the FIV-specific cytotoxic cell response and show that precursor cells appear in the circulation very early after infection and prior to a detectable antibody response. Our results also suggest that the persistent high-level circulating antiviral cytotoxic T-lymphocyte responses seen in human immunodeficiency virus-infected humans may not be a feature of FIV infections in cats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709246      PMCID: PMC190644          DOI: 10.1128/JVI.70.9.6199-6206.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Induction of IL-2 and lymphokine activated killer cells in the cat.

Authors:  M B Tompkins; G K Ogilvie; R A Franklin; K W Kelley; W A Tompkins
Journal:  Vet Immunol Immunopathol       Date:  1987-09       Impact factor: 2.046

Review 2.  Cellular and humoral mechanisms of cytotoxicity: structural and functional analogies.

Authors:  J D Young; Z A Cohn
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

3.  Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones.

Authors:  K K Sethi; H Näher; I Stroehmann
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

4.  Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.

Authors:  T Toyosaki; T Miyazawa; T Furuya; K Tomonaga; Y S Shin; M Okita; Y Kawaguchi; C Kai; S Mori; T Mikami
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients.

Authors:  B Autran; C M Mayaud; M Raphael; F Plata; M Denis; A Bourguin; J M Guillon; P Debre; G Akoun
Journal:  AIDS       Date:  1988-06       Impact factor: 4.177

6.  AIDS virus-specific cytotoxic T lymphocytes in lung disorders.

Authors:  F Plata; B Autran; L P Martins; S Wain-Hobson; M Raphaël; C Mayaud; M Denis; J M Guillon; P Debré
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

7.  Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.

Authors:  K J Weinhold; H K Lyerly; T J Matthews; D S Tyler; P M Ahearne; K C Stine; A J Langlois; D T Durack; D P Bolognesi
Journal:  Lancet       Date:  1988-04-23       Impact factor: 79.321

8.  Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.

Authors:  P Langlade-Demoyen; N Ngo-Giang-Huong; F Ferchal; E Oksenhendler
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.

Authors:  K A Reimann; K Tenner-Racz; P Racz; D C Montefiori; Y Yasutomi; W Lin; B J Ransil; N L Letvin
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope.

Authors:  J T Safrit; C A Andrews; T Zhu; D D Ho; R A Koup
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  19 in total

1.  Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.

Authors:  J N Flynn; C A Cannon; J C Neil; O Jarrett
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication.

Authors:  I S Choi; R Hokanson; E W Collisson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Lentivirus-specific cytotoxic T-lymphocyte responses are rapidly lost in thymectomized cats infected with feline immunodeficiency virus.

Authors:  Kathleen A Hayes; Sadi Köksoy; Andrew J Phipps; Wayne R Buck; Gary J Kociba; Lawrence E Mathes
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection.

Authors:  M J Hosie; J N Flynn
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.

Authors:  J Norman Flynn; Mauro Pistello; Patrizia Isola; Lucia Zaccaro; Barbara Del Santo; Enrica Ricci; Donatella Matteucci; Mauro Bendinelli
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

6.  Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes.

Authors:  J N Flynn; C A Cannon; D Sloan; J C Neil; O Jarrett
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

7.  Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes.

Authors:  J N Flynn; L Hanlon; O Jarrett
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

8.  Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection.

Authors:  J Norman Flynn; Stephen P Dunham; Vivien Watson; Oswald Jarrett
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 9.  Lentivirus-induced immune dysregulation.

Authors:  Mary B Tompkins; Wayne A Tompkins
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

Review 10.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.